medigraphic.com
SPANISH

Revista Cubana de Cardiología y Cirugía Cardiovascular

ISSN 1561-2937 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number S1

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2019; 25 (S1)

Convalescence phase of cardiac rehabilitation in patients with acute myocardial infarction in Las Tunas

González GJR, Santos MM, Batista BS, Ojeda RY, Peña ZR
Full text How to cite this article

Language: Spanish
References: 19
Page:
PDF size: 577.45 Kb.


Key words:

acute myocardial infarction, cardiac rehabilitation, convalescence phase, risk factors.

ABSTRACT

Introduction: Cardiovascular rehabilitation programs are one of the most effective tools for secondary prevention in patients after having suffered an acute myocardial infarction. Objective: To characterize cardiac rehabilitation in the stage of convalescence in patients after acute myocardial infarction.
Method: A descriptive and cross-sectional study was carried out in the Cardiology Service of the General Teaching Hospital ―Dr. Ernesto Guevara de la Serna ‖from Las Tunas between June 2016 and December 2017. The universe consisted of all patients discharged with a diagnosis of acute myocardial infarction referred to rehabilitation. The sample was established by the 55 patients who were able to collect all the variables of the study. Descriptive statistics were used through percentage analysis and arithmetic mean for quantitative variables.
Results: 83.7% were male. The average age was 55 + 8 years. Arterial hypertension was present in 96.4%, while 58.2% of patients were overweight and / or obese. 80% of patients admitted to cardiac rehabilitation presented KK I during hospital admission. 98.2% were treated with platelet antiaggregants, 96.4% with statins and 95.4% with angiotensin converting enzyme inhibitors. Only 9.1% had severe risk prior to the start of rehabilitation. At the end of the convalescence phase, the average of the cholesterol values (4.1 vs. 3.9), triglycerides (1.6 vs. 1.2) and the average of the body mass index (26.7 vs. 25, are reduced). 3), as well as the number of positive ergometries. A higher heart rate is reached (128 + 10 vs 135 + 9), systolic blood pressure (144 + 15 vs. 159 + 10), and double product (18320 vs. 21510) at the end of rehabilitation. In 94.6% there were no complications.
Conclusions: At the end of the convalescence phase, the average of cholesterol, triglyceride values, the average body mass index, as well as the number of positive ergometries is reduced. It is possible to improve the functional capacity and hemodynamics to physical exertion, with low percentages of complications during rehabilitation.


REFERENCES

  1. Perk J, De Backer G, Gohlke H, Graham I,Reiner Z, Verschuren M, European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2012;33:1635-701. Disponible en: 10.1093/eurheartj/ehs092

  2. Braunwald E, Zipes D, Libby P. Braunwald´sCardiología: El libro de medicina cardiovascular. 10ma Ed. Massachussets: W.B.Saunders Company, 2016; 1266-1352.

  3. Galve E, Castro A, Cordero A, Dalmau R, FácilaL, García Romero A, et al. Temas de actualidad en cardiología: riesgo vascular y rehabilitación cardiaca. Rev Esp Cardiol. 2013;66:124-30. Disponible en: DOI: 10.1016/j.recesp.2012.10.009

  4. Gielen S, Landmesser U. The Year in Cardiology2013: cardiovascular disease prevention. Eur Heart J. 2014;35:307–12.

  5. Bjarnason-Wehrens B, McGee H, Zwisler AD,Piepoli MF, Benzer W, Schmid JP, et al; Cardiac Rehabilitation Section European Association of Cardiovascular Prevention and Rehabilitation. Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey (ECRIS). Eur J Cardiovasc Prev Rehabil. 2010;17:410-8. Disponible en: doi: 10.1097/HJR.0b013e328334f42d

  6. Pleguezuelos E, Miranda G, Gómez A, CapellasL.Rehabilitación cardiaca en España. EncuestaSORECAR. Rehabilitación (Madr) 2010;44(1):2-7. Disponible en: https://www.sciencedirect.com/science/article/pii/S0048712011000764

  7. Corrà U, Piepoli MF, Carré F, Heuschmann P,Hoffmann U, Verschuren M, et al. European Association of Cardiovascular Prevention and Rehabilitation Committee for Science Guidelines (EACPR). Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur Heart J. 2010;31:1967-74.

  8. Ilarraza H, Herrera R, Lomelí A, Zavala J,Martínez L, Ramos FJ, et al. Registro Nacional sobre Programas de Rehabilitación Cardiaca en México. Arch Cardiol Mex. 2009;79:63-72. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1405-99402009000100012

  9. Cándido E, Richards JA, Oh P, Suskin N, ArthurHM, Fair T,et al. The relationship between need and capacity for multidisciplinary cardiovascular risk-reduction programs in Ontario. Can J Cardiol. 2011;27:200-7. Disponible en:doi: 10.1016/j.cjca.2011.01.008.

  10. Gómez González AM, De Torres I, Denia MartosC, Torres Jiménez AJ, Montiel Trujillo A, Bravo Escobar R, et al. Infarto-reinfarto: estudio comparativo clínico funcional en un programa de rehabilitación cardiaca. Rehabilitación (Madr). 2014;48(1):9-16. Disponible en: DOI: 10.1016/j.rh.2013.08.002.

  11. Beckie TM, Beckstead JW. Predicting cardiacrehabilitation attendance in a gender-tailored randomized clinical trial. J Cardiopulm Rehabil Prev 2010; 30(3):147-56.

  12. Pouche M, Bernard Ruidavets J, Ferrieres J,Christine Iliou M, Douard H, Lorgis L, et al. Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI study. Archives of Cardiovascular Disease (2016) 109, 178—187.

  13. Berenquel Senén A, Martín Sierra C, GallangoBrejano M. Actualización en rehabilitación cardiaca y prevención secundaria. Medicine. 2017;12(37):2232-42.

  14. Flores-Mateo G, Grau G, O’Flaherty M, RamosR, Elosua R, Violan-Fors C, et al. Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: España 1988-2005. Rev Esp Cardiol. 2011;64: 988–96.

  15. EUROASPIRE IV: A European Society ofCardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016 Apr;23(6):636-48. Disponible en: doi. 10.1177/2047487315569401

  16. Lavie C, Milani R: Cardiac Rehabilitation andExercise Training Programs in Metabolic Syndrome and Diabetes. Journal of Cardiopulmonary Rehabilitation 2005; 25: 59-66.

  17. Ilarraza Lomelí H. Impacto de la rehabilitacióncardiaca en el perfil de riesgo coronario. Arch Cardiol Mex. 2014; 77(4): 48-55

  18. García Porrero E, Andrade Ruíz M, SosaRodríguez V. Rehabilitación de los pacientes después de la colocación de una endoprótesis coronaria. Rev Cubana Cardiol Cir Cardiovasc 2011; 17 Supl 1: 65-74.

  19. Arramendi JF, Emparanza JI. Resumen de lasevidencias científicas de la eficacia del ejercicio físico en las enfermedades cardiovasculares. Rev Andal Med Deporte. 2015; 8(3):115-29. Disponible en: http://creativecommons.org/licenses/by-nc-nd/4.0/.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Cardiol Cir Cardiovasc. 2019;25